A Pilot Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368, a FAAH/MAGL Inhibitor, in Participants With Post-Stroke Spasticity (The STIPS Study)

NCT07704840 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Post-Stroke Spasticity

Interventions

DRUG: Administration of BMS-986368
DRUG: Placebo

Sponsor

Alberto Esquenazi

Collaborators

[object Object]